ACP-ASIM Information: Membership
Change of
Address Residency
Database CME
Career Resource
Center Where we stand
Discussion
Groups Annals
Committees
Computers/Medicine
IM
Bookmarks Medline
|

Missouri Resident Poster Competition 1999
Heidi M. Crane
M.D.
Washington University
Acute myocardial
infarction as an unusual presentation of chronic myelogenous
leukemia
Introduction: Chronic myelogenous leukemia is a rare
hematological neoplasm ( less than 15% of leukemias). Patients
typically present with fatigue, headache, weight loss or are
diagnosed from routine leukocyte counts obtained for other
reasons. This is an unusual case of a young woman with no
cardiac risk factors who presented with an acute myocardial
infarction.
Case: A 48-year-old female with no significant past medical
history was admitted to the hospital after one week of chest
pain. Pain typically began at night, usually at rest, often
would wake patient from sleep. Initially pain did not radiate
nor was it associated with nausea, vomiting, or diaphoresis.
On night of admit pain was more severe than previously, it
radiated to her left arm, and she vomited two times. At that
point she went to the hospital. After receiving aspirin and
nitrates patient had substantial reduction in pain. Initial
laboratory studies showed a troponin level of 4.1, a white
blood cell count of 88,000, a platelet count of 2.4 million,
and a hematocrit of 36. An EKG revealed a sinus tachycardia
with T wave inversions in V2 and V3, an echocardiogram showed
apical akinesis and anteroseptal hypokinesis. A cardiac
catheterization demonstrated a 90% LAD lesion which was
treated with percutaneous tranSt. Louis University minal
coronary angioplasty as well as a stent, in addition, spasm
was present at other sites, No reoccurrence of chest pain
occurred after the cardiac catheterization. Patient’s
treatment included platelet phoresis, aspirin, plavix, calcium
channel blockers, and initially hydroxyurea myelogenous
leukemia. Patient recovered uneventfully from the acute event.
Discussion: Acute myocardial infarctions can be due to a
number of pathologic hematologic abnormalities including
polycythemia vera, acute myelocytic leukemia, and others. An
acute myocardial infarction as a presenting symptom for
chronic myelogenous leukemia is exceeding rare especially in
the setting of no cardiac risk factors. This case has value in
not only its unusual presentation, but also the treatment
questions that arise. As an example, one could suspect that
this patient would have benefited from a glycoprotein IIb/IIIa
inhibitor but there is no data. This leads to a number of
other questions such as dosing (standard versus dosing until a
percentage of platelets are affected), safety, etc. These
issues then have implications about treatments for more
standard acute myocardial infarctions.
|